Maze Therapeutics (MAZE) Interest & Investment Income (2024 - 2026)

Maze Therapeutics has reported Interest & Investment Income for 3 years, with the latest figure at $3.2 million in Q1 2026.

• Quarterly Interest & Investment Income rose 22.79% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 77.09% YoY) and the FY2025 annual result came in at $11.8 million, up 153.09% from the prior year.
• Interest & Investment Income fell to $3.2 million in Q1 2026 per MAZE's latest filing, from $3.5 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $3.5 million in Q4 2025 and troughed at $281000.0 in Q1 2024.
• A 3-year average of $2.2 million and a median of $2.6 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income jumped 830.6% in 2025, then increased 22.79% in 2026.
• Over 3 years, Interest & Investment Income stood at $1.5 million in 2024, then soared by 130.28% to $3.5 million in 2025, then fell by 8.02% to $3.2 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $3.2 million, $3.5 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.